1. Home
  2. SIEB vs UNCY Comparison

SIEB vs UNCY Comparison

Compare SIEB & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Siebert Financial Corp.

SIEB

Siebert Financial Corp.

HOLD

Current Price

$3.79

Market Cap

115.6M

Sector

Finance

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.23

Market Cap

121.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIEB
UNCY
Founded
1886
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.6M
121.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SIEB
UNCY
Price
$3.79
$6.23
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$44.50
AVG Volume (30 Days)
23.4K
384.0K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$90,289,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.39
N/A
Revenue Growth
8.32
N/A
52 Week Low
$2.08
$3.71
52 Week High
$5.77
$11.00

Technical Indicators

Market Signals
Indicator
SIEB
UNCY
Relative Strength Index (RSI) 72.02 57.10
Support Level $2.82 $6.31
Resistance Level $3.05 $6.95
Average True Range (ATR) 0.26 0.42
MACD 0.09 -0.00
Stochastic Oscillator 90.57 53.72

Price Performance

Historical Comparison
SIEB
UNCY

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: